ATTACKPOINT DISCOVERY
Live / Applied — Non-final action mailed (as of 19 Feb 2026)
What this means for you
Not registered yet, but its 29 Aug 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79439112
- Mark type
- Stylized text
- Filed
- 29 Aug 2025
Goods and services
- Class 042 — Scientific and technological services: Research and development services in the field of pharmaceuticals and drug discovery; development of processes and methods for medical and veterinary purposes; development of preparations for medical and veterinary purposes; scientific research for medical purposes, namely, screening for the identification of drug candidates; development of precision RNA therapeutics; development of tailored RNA-based corrective interventions to target the root causes of serious diseases; research and development of new medical products for others; development and identification of novel druggable sites for pharmacological intervention using a bioinformatic discovery platform in a wet lab; screening services, bioinformatics services and modelling services to harness natural processes and modulate gene expression through platforms to generate optimized small molecules, antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs).
Owner
Prosecution history
- 12 Mar 2026 — REFUSAL PROCESSED BY IB
- 20 Feb 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 19 Feb 2026 — REFUSAL PROCESSED BY MPU
- 24 Jan 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 23 Jan 2026 — NON-FINAL ACTION WRITTEN
- 13 Jan 2026 — ASSIGNED TO EXAMINER
- 14 Dec 2025 — APPLICATION FILING RECEIPT MAILED
- 14 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 11 Dec 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB